Xeris Biopharma President and COO Kevin McCulloch reports sale of shares worth $312,215

XERS•2026-11-06

Xeris Biopharma President and COO Kevin McCulloch sold 25,000 common shares on November 5, 2026, at $12.4886 each, leaving direct holdings of 1,559,208 shares.

Xeris Biopharma President and COO Kevin McCulloch reports sale of shares worth $312,215

1. Share sale

Related News

Ingredion publishes Q3 2026 earnings call transcript

Victory Capital faces shareholder lawsuits alleging misleading disclosures on First Eagle deal

NRP highlights increase in third-quarter distribution to $2.34 per unit

Sources

Xeris Biopharma President and COO Kevin McCulloch reports sale of shares worth $312,215

The Andersons presents long-term growth strategy centered on renewables expansion

Silgan Holdings amends credit agreement to facilitate MetalCo transactions